MD1652F2 - Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina - Google Patents

Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina Download PDF

Info

Publication number
MD1652F2
MD1652F2 MD97-0099A MD970099A MD1652F2 MD 1652 F2 MD1652 F2 MD 1652F2 MD 970099 A MD970099 A MD 970099A MD 1652 F2 MD1652 F2 MD 1652F2
Authority
MD
Moldova
Prior art keywords
leu
protein
ala
lys
asn
Prior art date
Application number
MD97-0099A
Other languages
English (en)
Other versions
MD1652G2 (ro
MD970099A (ro
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Bouteiller Christine Labit-Le
Pascal Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of MD970099A publication Critical patent/MD970099A/ro
Publication of MD1652F2 publication Critical patent/MD1652F2/ro
Publication of MD1652G2 publication Critical patent/MD1652G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
MD97-0099A 1991-03-29 1992-03-27 Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină MD1652G2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
PCT/FR1992/000280 WO1992017586A1 (fr) 1991-03-29 1992-03-27 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules et micro-organismes transformes

Publications (3)

Publication Number Publication Date
MD970099A MD970099A (ro) 1998-04-30
MD1652F2 true MD1652F2 (ro) 2001-04-30
MD1652G2 MD1652G2 (ro) 2001-12-31

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0099A MD1652G2 (ro) 1991-03-29 1992-03-27 Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină

Country Status (14)

Country Link
US (1) US5652123A (ro)
EP (1) EP0506574B1 (ro)
JP (1) JP2865423B2 (ro)
AT (1) ATE130869T1 (ro)
CA (1) CA2083826C (ro)
DE (2) DE506574T1 (ro)
DK (1) DK0506574T3 (ro)
ES (1) ES2054601T3 (ro)
GR (2) GR940300052T1 (ro)
HK (1) HK1007435A1 (ro)
HU (2) HU217099B (ro)
IE (1) IE72165B1 (ro)
MD (1) MD1652G2 (ro)
WO (1) WO1992017586A1 (ro)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
BR9607403A (pt) * 1995-02-10 1998-07-07 Novo Nordisk As Protease cultura biologicamente pura isolada processos de preparação de uma protease e de lavagem uso de uma protease composição detergente aditivo de detergente
CN1093174C (zh) * 1995-02-10 2002-10-23 诺沃奇梅兹有限公司 芽孢杆菌属蛋白酶
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
ES2277460T3 (es) 1998-12-14 2007-07-01 Genetics Institute, Llc Cadena del receptor de la citoquina.
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
EP1268794A2 (en) 2000-04-07 2003-01-02 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
DK2805728T3 (da) * 2003-12-23 2020-04-20 Genentech Inc Hidtil ukendte anti-IL13-antistoffer og anvendelser deraf
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
WO2006055638A2 (en) 2004-11-17 2006-05-26 Abgenix, Inc. Fully human monoclonal antibodies to il-13
WO2006124451A2 (en) * 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses
WO2007036745A2 (en) 2005-09-30 2007-04-05 Medimmune Limited Interleukin-13 antibody composition
KR101544108B1 (ko) * 2006-09-08 2015-08-13 애브비 바하마스 리미티드 인터루킨-13 결합 단백질
JP2010527916A (ja) * 2007-04-23 2010-08-19 ワイス・エルエルシー Ｉｌ−１３関連障害を治療する方法および組成物ならびにその治療をモニターする方法
AU2009283008A1 (en) * 2008-08-20 2010-02-25 Centocor Ortho Biotech Inc. Engineered anti-IL-13 antibodies, compositions, methods and uses
GB0904214D0 (en) * 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
SG10201802525QA (en) 2013-09-13 2018-04-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
KR102332302B1 (ko) 2013-09-13 2021-12-01 제넨테크, 인크. 세포주에서 숙주 세포 단백질 및 재조합 폴리펩티드 생성물을 검출 및 정량화하기 위한 조성물 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Also Published As

Publication number Publication date
EP0506574B1 (fr) 1995-11-29
ES2054601T3 (es) 1996-04-01
US5652123A (en) 1997-07-29
HU217099B (hu) 1999-11-29
CA2083826A1 (en) 1992-09-30
WO1992017586A1 (fr) 1992-10-15
DE69206301T2 (de) 1996-06-13
GR940300052T1 (en) 1994-08-31
MD1652G2 (ro) 2001-12-31
IE72165B1 (en) 1997-03-26
GR3019043T3 (en) 1996-05-31
CA2083826C (en) 1999-04-27
HU9203753D0 (en) 1993-03-29
JPH06500567A (ja) 1994-01-20
DK0506574T3 (da) 1996-04-09
HK1007435A1 (en) 1999-04-09
HUT68162A (en) 1995-05-29
ES2054601T1 (es) 1994-08-16
MD970099A (ro) 1998-04-30
EP0506574A1 (fr) 1992-09-30
JP2865423B2 (ja) 1999-03-08
ATE130869T1 (de) 1995-12-15
DE69206301D1 (de) 1996-01-11
IE921016A1 (en) 1992-10-07
DE506574T1 (de) 1994-11-17

Similar Documents

Publication Publication Date Title
MD1652F2 (ro) Proteina cu activitate de tip citochina, ADN recombinant, codificator pentru aceasta proteina, celule si microorganisme transformate, vector de expresie, procedeu de obtinere a proteinei si remediu care contine aceasta proteina
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
GR3026553T3 (en) Porcine CNP gene and precursor protein
HU9401989D0 (en) A novel human kunitz-type protease inhibitor and variants thereof
EP1531791A4 (en) PREVENTION AND REDUCTION OF BLOOD LOSS
AU1633200A (en) Human parathyroid hormone modifications, preparation and use
RU94036773A (ru) Домен i ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена i
CA2002924A1 (en) Anti-Thrombins
DE69201438D1 (en) Als therapeutika geeignete peptide.
CA2083837A1 (en) Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants
NZ334714A (en) Liver proteins as agents against autoimmune diseases
CA2077590A1 (en) Recombinant dna coding for a protein with endochitinase activity
EP0292257A3 (en) Peptides having anf activity
NO975565L (no) Benstimulerende faktor
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
EP0258203A3 (en) Novel substrate peptides
IL74703A (en) Process for the preparation of peptides and some tripeptides as intermediates therefor
EP0687685A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES
EP1908781A3 (en) Modulation of immune response and methods based thereon
WO1997012036A3 (en) Bone stimulating factor
IL115825A0 (en) Therapeutic protein
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos
CA2311684A1 (en) Chemically-modified g-csf

Legal Events

Date Code Title Description
PD99 Pending application
MK4A Patent for invention expired